Antimicrobial Resistance Pattern and Presence of Beta-Lactamase Genes in Pseudomonas aeruginosa Strains Isolated from Hospitalized Patients, Babol-Iran
Abstract
Background: Pseudomonas aeruginosa has recently emerged as one of the main causes of nosocomial infections in the intensive care unit due to vast antibiotic resistance potency. The aim of this study was to investigate the antimicrobial resistance pattern and evaluation of the frequency of beta-lactamase genes in Pseudomonas aeruginosa strains.
Methods: Generally, 42 P. aeruginosa strains were collected from different clinical specimens. The phenotypic and genotypic tests such as disc diffusion, Modified Hodge test and molecular detection of blaIMP, blaIMP1, blaVIM2, and blaKPC genes were performed.
Results:According to the results, by disk diffusion method 33 (78.58%) to Cefotaxime, 31 (73.8%) of strains were resistant to Ceftriaxone, and 31 (73.8%) to Co-trimoxazole, while the lowest resistance was observed in case of Polymyxin B 3 (7.15%). On the other hand 4 (9.52%) of strains were recognized as MHT positive. Moreover, 26 (61.9%) of isolates were detected as multi drug resistance strains. In addition, 2 (4.7%) of isolates harbored blaIMP, 2 (4.7%) blaIMP1 and 10 (23.8%) blaVIM2 genes, whereas the blaKPC gene was not reported.
Conclusion: According to the results, the prevalence of beta-lactamase genes and antibiotic resistance pattern in patients with high levels of hospitalization is essential. Therefore, it is necessary to identify the strains containing β-lactamase genes for better control and treatment.
2. Cross A, Allen JR, Burke J, et al. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis 1983; 5(Supplement_5):S837-S45.
3. Jefferies J, Cooper T, Yam T, et al. Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit–a systematic review of risk factors and environmental sources. J Med Microbiol 2012; 61(8):1052-61.
4. Huddleston JR, Zak JC, Jeter RM. Antimicrobial susceptibilities of Aeromonas spp. isolated from environmental sources. Appl Environ Microbiol 2006; 72(11):7036-42.
5. Howard C, van Daal A, Kelly G, et al. Identification and minisequencing-based discrimination of SHV β-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia. Antimicrob Agents Chemother 2002; 46(3):659-64.
6. Pitout JD, Gregson DB, Poirel L, et al. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Clin Microbiol 2005; 43(7):3129-35.
7. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39(6):1211.
8. Poirel L, Magalhaes M, Lopes M, et al. Molecular analysis of metallo-β-lactamase gene blaSPM-1-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother 2004; 48(4):1406-9.
9. Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob 2015; 45(6):568-85.
10. Rodrigues ACS, Chang MR, Nóbrega GD, et al. Metallo-β-lactamase and genetic diversity of Pseudomonas aeruginosa in intensive care units in Campo Grande, MS, Brazil. Braz J Infect Dis 2011; 15(3):195-9.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S25. CLSI, Wayne, Pennsylvania 19087 USA, 2016.
12. Moosavian M, Rahimzadeh M. Molecular detection of metallo-β-lactamase genes, blaIMP-1, blaVIM-2 and blaSPM-1 in imipenem resistant Pseudomonas aeruginosa isolated from clinical specimens in teaching hospitals of Ahvaz, Iran. Iran J Microbiol 2015; 7(1):2.
13. Lagatolla C, Tonin EA, Monti-Bragadin C, et al. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β-lactamase determinants in European hospital. Emerg Infect Diseases 2004; 10(3):535.
14. Ellington MJ, Kistler J, Livermore DM, et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J Antimicrob Chemother 2006; 59(2):321-2.
15. Wolter DJ, Khalaf N, Robledo IE, et al. Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican medical center hospitals: dissemination of KPC and IMP-18 β-lactamases. Antimicrob Agents Chemother 2009; 53(4):1660-4.
16. Mirbagheri SZ, Meshkat Z, Naderinasab M, et al. Study on imipenem resistance and prevalence of blaVIM1 and blaVIM2 metallo-beta lactamases among clinical isolates of Pseudomonas aeruginosa from Mashhad, Northeast of Iran. Iran J Microbiol 2015; 7(2):72.
17. Ahmadi A, Soltanpour MM, Imani Fooladi AA. Prevalency of imipenem-resistant bacterial strains isolated from hospital and accuracy of Iranian imipenem disc product. J Gorgan Univ Med Sci 2015; 17(1):61-6.
18. Zafer MM, Al-Agamy MH, El-Mahallawy HA, et al. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. BioMed Res Int 2014:101635.
19. Rahimzadeh Torabi L, Doudi M, Golshani Z, The frequency of blaIMP and blaVIM carbapenemase genes in clinical Isolates of Pseudomonas aeruginosa in Isfahan medical centers. Medical Journal of Mashhad Jul-Aug 2016: 59(3):139-147.
20. Aghamiri S, Amirmozafari N, Fallah Mehrabadi J, et al. Antibiotic Resistance Pattern and Evaluation of Metallo-Beta Lactamase Genes Including bla-IMP and bla-VIM Types in Pseudomonas aeruginosa Isolated from Patients in Tehran Hospitals. ISRN Microbiology 2014: 941507.
| Files | ||
| Issue | Vol 8 No 1-2 (2019) | |
| Section | Original Articles | |
| Keywords | ||
| Multi Drug Resistance Nosocomial Infections Pseudomonas aeruginosa. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
